Thanks. Excellent post! Just found the synopsis on Fox news when I did a google search for "immune system therapy leukemia." No wonder Merck took a shot here as it looks very promising and Bristol Myers is already moving in this space. OPXA could be the hot little bio that blows up big this year. I like that they changed the treatment name from tovaxin to Tcelna, better association with t-cells.